Metabolomics and Lipidomics for Biomarker Discovery and Clinical Translation

Quantitative Profiling of >1,200 Small Molecules and Lipids to Explore Disease Mechanisms, Therapeutic Effects, and Metabolic Phenotypes

Metabolomics and lipidomics offer a direct view of biological activity, capturing dynamic phenotypes that complement genomics, transcriptomics, and proteomics. These data are critical for understanding disease mechanisms, patient stratification, and therapeutic response. Biognosys, a leader in proteomics CRO services, now offers the biocrates MxP^® Quant 1000 kit, an established and standardized solution for absolute quantification of > 1,200 metabolites and lipids across > 100 biological pathways.

Scalable, quality-controlled workflow supports a wide range of matrices and species, delivering reproducible data across timepoints and study sites, ideal for longitudinal and large-scale studies. By integrating biocrates metabolomics and lipidomics into its portfolio, Biognosys expands its CRO expertise to enable comprehensive multiomic solutions for drug discovery and translational research.

Download Flyer